According to this NASH drug tracker site, IMM-124E has breakthrough therapy status with FDA. http://www.nashbiotechs.com/drugs_en/IMM124E.php
TGN Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27